Glyburide potassium

Description:
Glyburide potassium is a drug that belongs to the class of sulfonylureas and is used as an oral hypoglycemic agent. It acts by stimulating pancreatic beta cells to release insulin. Glyburide potassium has been shown to increase intracellular Ca2+ levels, inhibit ATP-sensitive K+ channels, and stimulate enzyme activities in human erythrocytes. The drug also inhibits sodium carbonate-induced ionotropic gelation in aqueous solutions. Glyburide potassium has been shown to be a potent inhibitor of high-sensitivity C-reactive protein (hsCRP) activity in vitro. It also inhibits neuronal function in vitro through its effects on monoclonal antibodies.